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ABSTRACT

Mouse embryonic stem cells can be differentiated into multiple cell types and can
serve as an excellent model for studying developmental processes in vitro. In particular,
stem cells can be differentiated into forebrain-like neurons, allowing investigation of
nervous system development at single cell resolution. Eph receptor tyrosine kinases and
their ephrin ligands play a critical role during in vivo cortical development, particularly
during axon guidance. Preliminary data has shown that EphRs and ephrins are expressed
during in vitro differentiation. In addition, we see EphA7 localization at the face of neural
rosettes, where it co-expresses with markers of neuroblast identity. However, the role of
Eph receptors and ephrins in neurogenesis is not well understood.
Previous literature had shown that ephrin-A5 and EphA7 can function to balance
cortical apoptosis during embryogenesis. We hypothesized that EphR/ephrin signaling
may be required to balance apoptosis during in vitro neural development. A monolayer
differentiation protocol was used to generate cells of forebrain fate at high yield. RNAi
knockdown of EphA3, EphA4, and EphA7, was used to identify which Eph receptor was
contributing to the apoptotic effect individually. It was found that transient knockdown of
EphA3 and EphA4 fail to cause changes in apoptosis levels. However, knockdown of
EphA7 at differentiation days 4 through 8 lead to a reduction in apoptosis suggesting that
EphA7 can positively regulate cell death during differentiation. These data confirm that
in vivo developmental events such as apoptosis can be modeled in an in vitro system. The
innovative methods developed throughout the process of this research project may
eventually prove to be useful in the analysis of other neurodevelopmental processes.
iv

Key Words: embryonic stem cell, in vitro differentiation, neurogenesis, ephrin, Eph
receptor, apoptosis, siRNA, cell sorter, transfection, flow cytometry.

Abbreviations:
mESC: mouse embryonic stem cell
ICM: inner cell mass
EphR: Erethropoeitin-producing hepatocellular receptor
GPI: glycosyl phosphatidylinositol
RTK: receptor protein-tyrosine kinase
PCD: programmed cell death
TNFR: tumor necrosis factor receptor
dsRNA: double stranded ribonucleic acid
siRNA: small interfering ribonucleic acid
FACS: fluorescence activated cell sorting
RT-PCR: reverse transcription-polymerase chain reaction
GFP: green fluorescent protein
DAPI: 4',6-diamidino-2-phenylindole
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CHAPTER 1: INTRODUCTION

Mouse Embryonic Stem Cells
Embryonic stem (ES) cells are “pluripotent” cells meaning that in theory they are
able to differentiate into any tissue or cell type, as opposed to “multipotent” cells which
have lineage restriction to differentiate to cell types within the same progenitor type(1) .
In 1908, the Russian scientist Alexander Maksimov assigned the term “stem cell” to
describe cells that had “self-renewal” properties, progressing through numerous cycles of
cell division while preserving their original or undifferentiated state(2) . In 1981 the first
mouse embryonic stem cells (mESCs) were extracted from the inner cell mass (ICM) of a
mouse embryo(3, 4) . In 1998, the embryonic stem cell line was revealed as a
revolutionary scientific platform for their ability to accurately illustrate developmental
processes in vitro(5) . Thompson and his team used donated human embryos, originally
intended for in vitro fertilization, to conclude that the high telomerase activity exhibited
in stem cells contributes to their infinite replicative life span(5) .
Today, targeted ES cell differentiation for the generation of new neurons holds
excellent promise for those diagnosed with degenerative brain disorders such as
Alzheimer’s or Parkinson’s disease(6, 7) . In addition, because stem cells can be grown
indefinitely in culture, they can serve as a cost effective model for studying
developmental processes. Finally, new possibilities have arisen from the potential ability
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to repair damaged neural tissue by using embryonic stem cells to generate neural stem
cells(8) .
The differentiation of stem cells into neurons has been optimized using a
monolayer differentiation protocol developed by Austin Smith(9) . Typically, when stem
cells are allowed to freely differentiate into other cell types in culture, the outcome can
yield variable and heterogeneous outcomes. However, this in vitro differentiation
protocol generates cells in high yield that are broadly of forebrain fate. This method not
only allows the study of neurogenesis in vitro at single cell resolution but also provides a
platform to examine intrinsic and extrinsic mechanisms involved in neural specification
provided by signaling(10-12) .
Neurogenesis and the Role of Ephrins
The initial stage of vertebrate neurogenesis includes the induction and patterning
of a neuron forming or neurogenic region along the primitive streak, followed by the
birth and migration of neurons and glial cells (Figure 1) (13) . Next, axonal growth cones
migrate towards their designated targets and subsequently form synaptic connections(14)
. Many regions of the brain, including the cortex, develop in a layer-specific manner(1518) . The layer in which a neuron resides is closely matched with its birth in comparison
to neurons in other layers(19) . For instance, the oldest neurons can be found in the
deepest cortical layer whereas youngest neurons exist in the outermost layer(20, 21) .
One can confirm the layer fate of a specified neuron by examining the expression of
genes in that layer specific region(22) .
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FIGURE 1: Stages of Neurogenesis
The first stage of neurogenesis is the induction and
patterning of a neurogenic regions and specification of
cell fates. The second stage is the birth and migration of
neuron and glial cells. This is followed by guidance of
axonal growth conges to form synaptic
syn
connections.

During brain development, many regions of the brain connect in a topographic
manner, i.e. adjacent neurons in one region maintain their neighbor
neighbor-neighbor
neighbor relationship
when
en they extend axons into another region (23) . Responsibility
esponsibility during this stage of
neurogenesis is allocated to the Eph receptor tyrosine kinases and their
ir cognate ephrin
ligands. These are expressed in gradients, and utilize signaling to serve as positioning
labels for the refinement of this neural map (24, 25) .
Ephrin signaling Erethropoeitin-producing
producing hepatocellular (Eph) receptors are the
largest known family of receptor protein
protein-tyrosine
tyrosine kinases (RTKs) and function via direct
cell-cell
cell interaction with their cognate ephrin ligand
ligand(26) . Eph/ephrin signaling is
required for multiple aspects of central nervous
vous system development including mediation
of axon guidance by forward signaling or promotion of angiogenesis for the distribution
of the blood supply(14,
(14, 27) . The ephrins and their EphR receptors
eptors are categorized into
two main classes based on sequence homology and structural composition,
composition EphA and
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EphB. The ephrins are composed of GPI anchored ephrin-A ligands and single-pass
transmembrane ephrin-B ligands (Figure 2).

FIGURE
2:
Structure
and
sequence homology of the Eph
receptor and ephrin families
Structural elements include: Cysrich, a unique cysteine rich domain
found in the Eph receptors; FNIII,
fibronectin type III motif; TM,
transmembrane
domain;
GPI,
glycosyl
phosphatidylinositol
membrane anchor; Core, a conserved
core sequence in the ligands
containing four invariant cysteines.

Ephrin-As have a high affinity for EphA receptors and ephrin-Bs typically bind
EphB receptors, although some promiscuity does exist (Figure 3). For instance, evidence
of cross reactivity has been published where ephrin-A5 binds to and activates the EphB2
receptor(28) . Examples of signaling capabilities include ephrin-A signaling pathways
that are responsible for integrin function and Ephrin-B/EphB interactions that create the
cell-cell repulsion that allow for organization of hindbrain segments(29, 30) . Ephrin-B2
is also responsible for axon retraction in retinal ganglion cells from distinct retinal
regions(31) . Post-embryonically, ephrin signaling plays roles in synaptic plasticity, nerve
regeneration, cancer progression, and pathological angiogenesis (32-35) .
EphR signaling can repulse axons from inappropriate target fields (Figure 1).
EphRs and ephrins can also engage in bi-directional signaling. Forward signaling occurs
when the ephrin sends positive cues to the receptor-bearing cell, whereas reverse
signaling occurs downstream in the ligand-bearing cell. Reverse signaling is still not
completely understood but what has been determined is that once activated, can be
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responsible for the opposite reaction such as growth cone extension instead of the typical
growth cone collapse(31, 36) .

FIGURE 3: Binding interactions between ephrins and
their receptors
Dual colored indicates cross reactivity with the opposing
classes. For example, ligand ephrin-A5 primarily interacts
with the EphA family of receptors (yellow), although it more
weakly interacts with the EphB family of receptors (purple).
EphA10 specific binding partner has yet to be determined(35).

As mentioned previously, connectivity mapping during the development of the
visual cortex also relies on signaling from ephrins (37) . Also, negative signaling cues
provided by EphrinA2 can regulate proliferation in addition to controlling the
approximate number of neural cells in the progressing brain(38) . Finally, ephrin
signaling is implicated in controlling growth cones and cortical column formation(39, 40)
. In summary, the organization of the nervous system during early development relies
heavily on signaling from EphRs and ephrins, playing critical roles in proper cortical
development, axon guidance, apoptosis, and cell polarity(41-44) .
Apoptosis in Early Neurogenesis
During mammalian development, the elimination of cells by programmed cell
death (PCD) is a necessary event that allows multicellular organisms to regulate cell
numbers to remove cells that are functionally redundant(45) . Apoptosis can also
eradicate cells that are potentially detrimental to the organism(45) . In addition to
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providing positive or negative directional cues for axon outgrowth, ephrin signaling is
also required in apoptotic pathways to regulate brain size. Typically, programmed cell
death (PCD) or apoptosis is required during normal mammalian development as a
pruning mechanism to remove unnecessary structures, for example by removing skin
between fingers and toes for segmented digits(46) .
Ephrin signaling is essential to balance the size of the neural progenitor cell
population in early neurogenesis. Furthermore, over-activation of EphA signaling in vivo
increases the rate of apoptotic death(47, 48) . The mechanism for which apoptosis is
initiated by ephrins is not fully understood although one recent study indicated that
EphA7 was physically associated Caspase-8 to induce apoptosis(49) . Furthermore,
EphA7 is co-localized with tumor necrosis factor receptor 1 (TNFR1) on the cell surface,
a well-known player in the extrinsic apoptosis pathway (49). This interaction is lost once
TNFR1 undergoes endocytosis, which confirms that apoptosis is initiated once EphrinA5
binds to EphA7 and activates the death receptor TNFR1 by physical association(50) .
Additional results from an in vivo study have shown that together, ephrinA5 and EphA7
may function to balance cortical apoptosis to control overall neuronal mass(43) . This
article demonstrated that over-expression of ephrinA5, driven from the EphA7 promoter,
can lead to increased apoptosis. In addition, ephrinA5/A2 double mutant mice can display
a reduction in apoptosis during neural patterning(43) .
Based these in vivo results, we set out to explore whether EphA signaling has a
role in neuroblast apoptosis during in vitro differentiation. The hypothesis is that (1) Eph
receptor and ephrin expression is conserved in vitro during the stem cell-to-forebrain
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differentiation and (2) EphR/ephrin signaling is functioning to balance apoptosis during
neural development.
In this study an in vitro system utilizing a stem cell-to-forebrain model with two
different stem cell lines, Sox1-GFP and Oct4-GFP, was used to monitor the stem cell-toneuron transition while characterizing changes in apoptosis levels. Through the use of
ezRNAi transfections, knockdown of EphA3, EphA4, and EphA7 receptor gene
expression was monitored to evaluate which Eph receptor was contributing to the
apoptotic effect individually. Findings from this project are the first in vitro assay
allowing for visualization of how exactly EphA7 is participating in cortical maturation
through apoptotic mechanisms.
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CHAPTER 2. MATERIALS AND METHODS

Stem Cell Culture and Maintenance
The following mouse embryonic stem cell lines ((mESCs)) were used throughout
the duration of these thesis studies; Oct4-GFP(51) and Sox1-GFP(9) (Figure 4).
4 These
cell types have been derived from the E14Tg2A cell line. Both cell types were
propagated as feeder-free
free cultures on 0.1% gelatin-coated
coated plastic in sterile-filtered
Glasgow modified Eagles medium supplemented with 1mM Sodium Pyruvate,
Pyruvate 2mM LGlutamine, 1X non-essential
essential amino acids
acids, 0.05mM Beta-mercaptoethanol,
mercaptoethanol, 1X
Penicillin/Streptomycin, and 10% fetal bovine serum. 2U/uL of leukocyte
ukocyte inhibitory
factor was added to 50mL aliquots of filtered media prior to usage. 5ml cultures were
seeded at 5x105 cells in T
T-12.5
12.5 flasks. These cultures were split every two days and
counted; media was replaced with fresh media on non
non-split days.

Figure
igure 4:
4 GFP
expression in
undifferentiated vs.
differentiated cells
Oct4-GFP
Oct4
stem cells (top
row) are fluorescent and
become non-fluorescent
non
upon
differentiation.
Cells are shown prior to
differentiation. Sox1-GFP
Sox1
cells (bottom row) are
non-fluorescent
non
as stem
cells but express GFP
during
neural
differentiation. Shown are
Day 8 neuroblasts.
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Neural Differentiation
Neuronal differentiation was carried out essentially as previously described (9)
but with additional full volume media changes as necessary to remove cellular debris and
dead cells. Differentiation was initiated at day 0 by plating stem cells on 0.1% gelatincoated plastic surfaces at low density in N2B27 media. Seeding densities were as follows;
1.9x104 cells per well of a 24-well plate or 2.1x105 cells per 6cm plate. After 5 days postdifferentiation, the cells were re-plated onto poly-ornithine and laminin-coated surfaces
and seeded as follows; 3.8x104 cells per well of a 24-well plate or 4.2x105 cells per 6cm
plate.
Alternative Media and Differentiation Supplements
An alternative to the Invitrogen supplied supplement is GEM 21 supplied by
Gemini Biosciences. Neuroplex, which is compatible with the GEM 21 supplements, may
be used in lieu of Neurobasal.
Polymerase Chain Reaction (PCR)
Forward and reverse primers for each fragment of the EphA receptors were
designed by Bryan Lynn and ordered through Life Technologies (Appendix A).
Polymerase chain reaction (PCR) was used to amplify 500-700bp fragments of each
EphA receptor (EphA3, EphA4, or EphA7) that had been previously cloned into the
pCR8/GW/TOPO plasmid by Cory Donelson (Figure 8). Second round PCR was used to
extend a T7 promoter region onto the EphA receptor sequences for adequate
transcription. The same was followed for attaching the T7 promoter region on the GFP
cDNA sequence. The 2X primer mix contained Taq, dNTPs, and PCR buffer. Aliquots of
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products (2uL each) were analyzed via 2% agarose gel in TAE buffer stained with
Ethidium Bromide.
Table 1: PCR Reaction Mix and Thermocycler Programming

PCR Reaction

Amount

Temp

Time

DI H2O

9.5 uL

1) 94OC

2 min

2X PCR Mix

12.5 uL

2) 94OC

20 sec

F. Primer (10uM)

1.0 uL

3) 50OC

30 sec

R. Primer (10uM)

1.0 uL

4) 72OC

45 sec

PCR Template

1.0 uL

5) Go to #2

35 times

Total Mix

25.0 uL

6) 72OC

5 min

RNA Transcription
In vitro RNA Transcription was carried out using the Ambion MEGA Script Kit
supplied by Life Technologies using the protocol and incubation temperatures outlined
below. Aliquots of products (1uL each) were analyzed via 2% agarose gel. The gel was
prepared with DEPC treated TAE buffer and Ethidium Bromide. Gel running conditions
were at 100 Volts in a DNase/RNase free environment (gel tank and running buffer).
Table 2: RNA Transcription Reaction Mix and Thermocycler Programing

Reaction

Amount

Temp

Time

DI H2O

6.0 uL

1) 37OC

4 hours

NTPs

8.0 uL

2) 90OC

3 min

O

3 min

4) 70 C

3 min

5) -0.1OC

3 min

3) -0.1 C
10X Reaction Buffer

O

2.0 uL

O

PCR Product DNA

2.0 uL

6) 50 C

3 min

T7 Enzyme

2.0 uL

7) -0.1OC

3 min

Total Mix

20.0 uL

8) 25OC

3 min
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Generation of siRNAs by RNase III Digest
The double stranded ribonucleic acid (dsRNA) products were digested with
RNase III (New England BioLabs Inc.) to yield 20-23 base pair fragments of dsRNA or
small interfering RNA (siRNA) according to the protocol outlined below(52) .
Table 3: RNase Digestion with NEB Shortcut RNase III

Reaction

Amount

Temp

Time

DEPC H2O

65.0 uL

1) 37OC

30 min

dsRNA (20ug)

5.0 uL

2) 0OC

Place on Ice

10X NEB Buffer

2.0 uL

3) Add 10uL EDTA

Immediately

10X MnCl2

2.0 uL

4) Purify

Immediately

NEB Shortcut RNase III

2.0 uL

Total Mix

100.0 uL

siRNA Purification
Fragmented siRNA was purified using RNA purification columns for small range
RNA (Zymo Research). The procedure was performed as per the manufacture’s protocol.
Transfections
For EphA receptor knockdown, purified siRNAs were transfected into cells using
Lipofectamine 3000 (Life Technologies), 24 hours prior to analysis. Cells in culture were
allowed to adhere on the gelatin coated surfaces for 24 hours prior to transfection. Cells
in suspension were transfected directly into OPTIMEM and analyzed 24 hours later.
pCAGGS-mCherry plasmid (kind gift of Bin Chen) was used as a co-transfection control
to detect successful transfection of our RNAi constructs.
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Table 4: Transfection with mCherry and siRNA Products

Reagent

Stock Concentration

Final Concentration/Well

Sham Transfected

Lipo 3000

2.0uL

GFP siRNA

265ng/uL

125ng, 250ng, or 500ng

mCherry Plasmid (Prep 1)

678ng/uL

mCherry Plasmid (Prep 2)

179ng/uL

250ng, 500ng, or 1ug

EphA3 siRNA

365ng/uL

250ng or 500ng

EphA4 siRNA

119ng/uL

250ng or 500ng

EphA7 siRNA

566ng/uL

250ng or 500ng

Total Volume Transfected

100uL/well

Bioinformatics Assessment of Potential Cross-Binding
Basic Local Alignment Search Tool (BLAST) searches of the GFP siRNA
products were analyzed for cross binding to mCherry (Appendix B)(53) .
Analysis of apoptosis by Annexin V binding and Flow Cytometry
Apoptosis was characterized at various timepoints ranging from Day 1 to Day 10
post-differentiation on the SH800 Sony Cell Sorter. Cells were lifted with Trypsin/EDTA
and neutralized with 10% BSA/90% PBS. Cells were spun down and resuspended in 1X
Binding Buffer (0.1M HEPES pH 7.4, 1.4M NaCl, and 25mM CaCl2 in 1X PBS). 5uL of
Cy5-labeled Annexin-V (BD Biosciences) was added to 100uL of resuspended cells for
15 minutes prior to adding 400uL of 1X Binding Buffer and analyzing by FACS.
Annexin-V binds directly to phosphotidylserine, and can be used to indicate cells
undergoing apoptosis versus necrotic cells. 25uL of a 5x 4',6-diamidino-2-phenylindole
(DAPI) stain (1000X stock), used as a live/dead marker, was added to 100uL of
resuspended cells and allowed to sit for 1 minute prior to analysis. Sox1-GFP and Oct4-
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GFP stem cells were used as our differentiation trackers to identify the percentage of
neuroblast cells in the population. Color compensation to remove spectral overlap
between mCherry and Annexin was carried using Sony SH800 software by analyzing
single color controls.
Confocal Microscopy
Cell morphology was analyzed at various time points ranging from Day 0 to Day
10 post-differentiation on a Zeiss LSM 700 confocal microscope. Post-transfection media
was removed and cells were rinsed with PBS. 200uL of 1X Binding Buffer (0.1M
HEPES pH 7.4, 1.4M NaCl, and 25mM CaCl2 in 1X PBS) was added to each well. 10uL
of Cy5-labeled Annexin-V (BD Biosciences) was added to 200uL of rinsed cells for 14
minutes prior to adding 50uL of 10X DAPI for an additional 1min. Solution was removed
and cells were rinsed with PBS. 200uL of 1X binding buffer was added to each well then
clusters of neuroblast were imaged. Oct4-GFP stem cells were used as our positive
control. GFP was targeted for knockdown with GFP siRNA at concentrations of 125ng,
250ng, and 500ng per well. The corresponding % GFP expression was quantified by
image analysis.
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CHAPTER 3. RESULTS

Ephrin and EphR Expression During in vitro Neurogenesis
To answer the first question of whether or not Eph receptor and ephrin expression
is conserved in vitro during the stem cell
cell-to-forebrain differentiation; expression
xpression of EphA
RTKs and their cognate ephrin
ephrin-A ligands were examined.. Quantification of mRNA levels
for EphAs and ephrin-As
As was performed (Figure 5). Using our stem cell-to-neural
cell
differentiations, we can confirm that EphR and ephrin transcript levels seen in vitro
broadly mirror previously published in vivo results (9) .

FIGURE 5: Quantification of RT-PCR
RT
profiles of
EphA and ephrinA
(
(A) mRNA expression levels for EphA receptors. (B)
mRNA levels of ephrin type A ligand expression. Data
are plotted relative to beta-actin
actin mRNA and is
representative of three independent differentiation
experiments. (Clay Hembree and Martin Hudson
unpublished observations)
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At day 0, EphA2 is highly expressed and drops to almost zero at day 5 and returns to
midlevel from day 8 to day 12. EphA4 expression is maintained throughout neural
differentiation. EphA7 expression is negligible at day 0, elevates to its highest peak at
day 5 and steadily declines in expression throughout day 12 post
post-differentiation.
differentiation. EphA3
expression is first seen around day 8 and continues to day 12. EphrinA5 expression can
be observed at day 5 post
post-differentiation and lingers until day 12. Overall, the expression
levels seen in vitro correspond closely to expression profiles observed during forebrain
development sequentially
uentially through time
time(11) .
Oct4 is often used as a universal marker for stem cell fate and our data has shown
loss of Oct4 at day 5 post differen
differentiation (Figure 6A).
A). This data has also indicated that at
day 5 post-differentiation,
differentiation, the majority of the cell population has lost stem cell
ce state and
transformed into the desired neuronal fate
fate, as demonstrated by high-level
level expression of
the pro-neural
neural transcription factor Sox1 (Figure 6B). Sox2 can serve as a stem cell
marker but it also required in maintaining the cell’s neural progenitor state. We observe a
decrease around day 5,, after which it maintains levels throughout the time points tested.

FIGURE 6: Quantitation of RT-PCR
PCR profiles of sstem cell and pro-neural markers
(A) mRNA expression level of Oct4 showing a loss of expression at day 5. (B) mRNA levels of Sox1 (pro-neural
(pro
marker) and
Sox2 (stem cell marker). Data are plotted relative to beta
beta-actin
actin mRNA and is representative of three independent differentiations.
(Clay Hembree and Martin Hudson unpublished observations)
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The Sox1 pro-neural
neural marker was expressed at constant levels throughout neural
differentiation, from day 5 onwards. The loss of Oct4 by day 5 and the increase in
expression of Sox1 agrees with other publications (9, 54) .
We used antibodies to demonstrate that EphA7 expression is detected in highest
magnitude at the surface of in vitro-generated neural masses and decreasing in a gradient
fashion towards the central most portion of the ne
neural mass (Figure 7).
). Because Nestin,
which is a signature for neuroblast identity, and EphA7 are co
co-localized
localized, this provides a
good indication that EphA7 is expressed in developing neuroblasts
neuroblasts(55)
(55) . Although we
see EphA7 expression in this cell type,, we do not know what role Eph/ephrin signaling is
playing during
uring in vitro differentiation.

Figure 7:: Distinct region of EphA expression in neural tissue
(A) Neural masses at differentiation day 12. The arrow indicates a EphA7 positive region located at the periphery. (B)
EphA7 expression at the cross-section
section between point’s m-n and p-q as noted on Figure 6A. (Clay
Clay Hembree and Martin
Hudson unpublished observations)
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Synthesis and Purification of EphA Receptor siRNA
Because the role of Eph/ephrin signaling during in vitro differentiation is not well
understood, we used a knockdown system involving siRNA to expose the role of EphA7.
Genetic mutations in the live mouse model are considered to be the gold standard for
examining gene function in vivo. However, the average time to generate a mouse
knockout takes about 18 mont
months,
hs, is quite costly and completely unfeasible in smaller
university laboratories. Here, we implement an in vitro model, which uses siRNA to
transiently knock down gene function allowing for a rapid, reliable, and cost-effective
cost
method that can be implement
implemented
ed in essentially any laboratory. Transfecting siRNAs for
gene silencing is a powerful genetic manipulation tool
tool(56) . The mechanism of siRNA
works by eliciting destruction of targeted mRNA stands by binding to the complementary
com
sequence promoting rapid destructio
destruction(52) . siRNAs were generated from cloned, nonnon
overlapping, EphA receptor fragments. In addition, GFP siRNAs were generated for use
in assay validation and controls.

FIGURE 8: Plasmid for cloning EphA receptors
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Polymerase chain reaction (PCR) was used to amplify the specified region portion
of each EphA receptor (EphA3, EphA4, or EphA7)
EphA7), and a GFP cDNA sequence (Figure
8). This PCR step also allowed us to add a T7 RNA polymerase recognition site onto
both ends of each fragment. Each DNA product was analyzed by agarose gel stained with
Ethidium Bromide (Figure 9). Each cloned DNA fragment was a single band
ba
that
indicates purity of each amplicon
amplicon.. The sizes were appropriate; EphA3 is 527 base pairs,
EphA4 is 567 base pairs, EphA7 is 639 base pairs, and the GFP fragment is 750 base
pairs in length.
The DNA fragments were then used as templates for in vitro transcription
reactions to generate dsRNA (Figure 10), which was subsequently digested
digest with RNase
III, yielding 20-23
23 base pair fragments of dsRNA. These were purified using RNA
purification columns.
s. RNaseIII digestion was confirmed by agarose gel electrophoresis
electrop
in
RNase/DNase free environment (Figure 11). siRNA products were quantified via
Nanodrop (Table 5). Due to the low yield of GFP siRNA, the dsRNA was re-digested and
re-purified.
purified. It was concluded that preparation error had occurred because preparation
preparati 2
had adequate amounts of siRNA post
post-purification.

FIGURE 9: DNA Templates
Aliquots of products (2uL each) containing
the T7 promoter site were analyzed via 2%
agarose gel in TAE buffer stained with
Ethidium Bromide.
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FIGURE 10: RNA Transcripts
Aliquots of dsRNA (2uL each) analyzed by 2% agarose gel in
stained with Ethidium Bromide run in a DNase/RNase free
environment. (Frank Tulenko and Marcus Davis unpublished
observations)

FIGURE 11: siRNA Products
Aliquots of purified siRNA (2uL each) analyzed by 3% agarose gel in
stained with Ethidium Bromide. (Frank Tulenko and Marcus Davis
unpublished observations)

Table 5: Nanodrop quantification of siRNA Products
siRNA

Concentration

EphA3

375ng/uL

EphA4

119ng/uL

EphA7

566ng/uL

GFP (Prep 1)

5ng/uL

GFP (Prep 2)

265ng/uL

Implementation of a Positive Control
To validate the siRNA delivery system, a GFP knockdown positive control was
implemented. Initially a low dose (50ng) of GFP siRNA was transfected into Oct4-GFP
stem cells and a time-course
course was applied to test the limits of the knockdown effect
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(Figure 12). The 50ng concentration was selected based upon previously published
data(57) .

GFP Knockdown Timecourse

% GFP Expressing Cells

100

81.3

81.1

80

77.3

71.1

66.3

63.5

60
40
20
0

FIGURE 12: GFP Knockdown Time-course
Time
Concentrations of 50ng of purified GFP siRNA
were transfected into cells seeded at 19,000
cells/well and were allowed to incubate for 24
hours in OPTIMEM before returning to stem
cell media. Populations of cell were counted
on the BD Accuri and were gated
appropriately. (Top) Flow cytometry data. XX
axis measuring GFP fluorescence. Y-axis
Y
measuring forward scattering. Cells gated as
positive for GFP fluorescence are gated within
the dotted lines. (Left) Quantification of flow
cytometry data, GFP-positive
positive cells.
ce

0ng GFP 50ng GFP 50ng GFP 50ng GFP 50ng GFP 50ng GFP
24hrs

24hrs

48hrs

72hrs

96hrs

120hrs

Timecourse

We observed a modest decrease in GFP expression after 96 hours post-siRNA
post
transfection. However, because a dramatic knockdown effect was desired, the GFP
siRNA was increased to concentra
concentrations of 125ng, 250ng and 500ng of siRNA per well.
Phenotypic GFP expression was recorded through confocal microscopy to show the
decrease in GFP fluorescing cells (Figure 13).
). This data was quantified by comparing
total GFP fluorescence to total transmission data. From the results it is easy to conclude
that a range of 125ng-500ng
500ng is sufficient to detect a concentration-dependent
dependent decrease in
GFP fluorescence, so it was decide
decided
d that 250ng of siRNA would be adequate to target
EphA knockdown. At 500ng GFP siRNA threshold levels exceed the amount of
lipofectamine and less siRNA is transfected, increase in GFP expression is observed.
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GFP Flourescence/Transmission

Confocal Quantitation of GFP Knockdown

0.18
0.16
0.14
0.12
FIGURE 13: Confocal analysis of
GFP knockdown

0.1
0.08
0.06
0.04
0.02
0
0ng 125ng 250ng 500ng
siRNA siRNA siRNA siRNA

Concentrations of 125ng, 250ng, and
500ng of GFP siRNA were transfected
into cells 24 hours prior to analysis.
The
Sham
transfection
was
lipofectamine 3000 alone. Cell clusters
for each condition were randomly
selected for analysis. Measurements
were calculated by dividing thresholded
GFP fluorescence pixels by the total
pixels in the cluster (measured from the
transmitted light channel).
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Co-Transfection Optimization
An mCherry co-transfection plasmid was used to detect successful transfection of
the siRNA products. This will allow for selective gating to exclude untransfected cells
from the population in evaluation. mCherry transfections were optimized in mESC media
and OPTIMEM for stem cells and N2B27 and OPTIMEM for neurons (Figure 14). 750ng
of plasmid was selected as a target range based upon recommendation by the
Lipofectamine 3000 protocol. Throughout the transfection experiments, all of the cells
were able to maintain resonable levels of viablity based on the percentage of live cells
reported.
Stem cells were transfected with mCherry in both mESC media and OPTIMEM
with about 30% transfection efficiency (Figure 14A). Therefore it can be concluded that
stem cells posses the ability to be transfected in both stem cell media and OPTIMEM.
Neurons were transfected with less efficiency in the OPTIMEM (13%) than the N2B27
media (24%). Based on the live cell population reported, the neuroblasts did not suffer
from the OPTIMEM media, although rather less mCherry was taken up by the
neuroblasts (Figure 14B).
Upon the deduction that stem cells are more easily transfected than neuroblasts
(Figure 14C), it was recommended to use GFP siRNA knockdown on day 3 neuroblasts
to test their ability to uptake GFP siRNA and to yield an observable reduction in GFP
fluorescence (Figure 15). Cells were assessed 24, 48, and 72 hours after transfection. The
experiment was set up in parallel with Day 0 stem cells for comparison purposes.
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Transfection Efficiency
% of Cells Expressing mCherry

C
40
35
30
25
20
15
10
5
0

31.38

32.4
24.33
FIGURE 14: mCherry transfection optimization

12.87

MEDIAOPTIMEM

N2B27OPTIMEM

Stem Cells

Neuroblasts

(A) Sox1-GFP
GFP undifferentiated stem cells were
transfected with Lipofectamine 3000 alone and 750ng
of mCherry plasmid. (B) Sox1-GFP
GFP differentiated
Day 1 neuroblasts were transfected with
Lipofectamine 3000 alone and 750ng of mCherry
plasmid. 24 hours post-transfection,
ransfection, the cells were
moved back to regular media and analyzed 48 hours
post-transfection.
transfection. (C). mCherry expressing cells were
quantified by the Sony SH800.
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Timecourse GFP KD
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% Cells Expressing GFP

% Cells Expressing GFP
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Control
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# Hours Post-Transfection
Transfection

48

72

# Hours Post-Transfection

FIGURE 15: Comparison of GFP knockdown in Day 0 and Day 3 Oct4
Oct4-GFP Cells
Cells were lifted and plated on gelatin
gelatin-coated
coated surfaces at 19,000 cells/well and allowed to settle for 24 hours prior to transfecting.
Concentrations of 250ng of GFP siRNA along with 1ug mCher
mCherry were transfected into Oct4-GFP
GFP (A) day 0 stem cells or (B) day
3 neuroblast 24 hours prior to analysis. At 24 hours the OPTIMEM was removed and replaced with (A) stem cell or (B) N2B27
media respectively. (C) Quantified population of GFP positive stem ccells
ells and (D) population of GFP positive neuroblasts.
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It was established that GFP knockdown was observed in both stem cells and
neuroblasts and has a lasting knockdown effect out until 72 hours post-transfection.
post
These finding suggest that mCherry can be considered a practi
practical co-transfection
transfection control
and that both stem cells and neuroblast
neuroblasts are susceptible to gene silencing via siRNA.
Apoptosis Method Validation
Flow cytometry was used to characterize apoptosis throughout the duration of this
thesis. Apoptosis
tosis was assayed aat various timepoints ranging from Day 1 to Day 10 postpost
differentiation, using both the BD Accuri flow cytometer and the Sony SH800 Cell
Sorter. The Accuri automatically establishes laser and filter setting
settings whereas the Sony
requires some manual integration parameters to ensure optimal data collection.
The first step when working with the Sony is to calibrate with the negative
control. Sox1-GFP
GFP day 0 stem cells were used as the negative control in these
experiments
riments because they contain no flu
fluorophores.
phores. The cells were spun down and
resuspended in 1X Binding Buffer and the
then each laser was set up to target the cell
population in the center of the viewing window (Figure 16
16). Single color controls can be
recorded to establish limits of detection for each fluorophore (Figure 17).
).

FIGURE 16: Gating for a negative control
Sox1-GFP
GFP stem cells were used to set up each laser setting. Brilliant Violet = DAPI (405nm), FITC = GFP (488nm),
PE = mCherry (561nm), and APC = Cy5
Cy5-Annexin (638nm).
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FIGURE 17: Gating for single color controls
(A) Brilliant Violet = DAPI (405nm) Sox1
Sox1-GFP
GFP cells incubated with 1X DAPI for 1min. (B) FITC = GFP (488nm) Oct4-GFP
Oct4
Stem Cells. (C) PE = mCherry (561nm) Sox1
Sox1-GFP stem cells
ells transfected with mCherry Plasmid. (D) APC = Cy5-Annexin
Cy5
(638nm) Sox1-GFP
GFP Stem Cells incubated with 1X Cy5
Cy5-Annexin for 15 minutes. Annexin-V
V binds directly to phosphotidylserine,
and can be used to indicate cells undergoing apoptosis versus necrotic ce
cells.

Automatic compensation can then be calculated using the gating from the
negative control and single color controls. The resulting calculations are generated and
can be applied to anyy subsequent data set (Figure 18
18). Occasionally
sionally manual compensation
is required to fine-tune
tune the removal of spectral overlap. In our case, incorporation of the
mCherry co-transfection
transfection plasmid to detect successful transfection of our RNAi
constructs, thought to be a useful efficiency control, led
d to complications.
complications Unfortunately,
the use of both mCherry and Annexin on the FACS required manual compensation due to
major spectral overlap.. Because of this, mCherry was not used in subsequent
experiments.
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FIGURE 18: Automatic color compensation
The automatic color compensation matrix was
calculated using single color controls.

mCherry expression is driven by the pCAGGS chicken actin promoter.
promoter This is a
very strong promoter, which leads to very high expression levels of mCherry causing the
signal to overpower that of the weaker Cy5 fluorophore. The major spectral overlap
between mCherry
ry and Annexin (Figure 19
19A) was accommodated
modated via manual
compensation (Figure 19B
19B).. Dragging the mCherry population back to its respective
quadrant adjusted the color compensation matrix (Figure 19C).
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FIGURE 21: Applying Manual
Color Compensation Calculation
Matrix
(A) Spectral Overlap between
mCherry and Cy5-Annexin
Annexin in the
emission spectra above, there is
heavy spillover from mCherry
channel into the Cy5-Annexin
Cy5
emission region. (B) Sample =
Neuroblast mCherry Transfected
Cells. (Left) No compensation
applied. (Center) Results from
Automatic compensation from single
color control matrix. (Right) (C)
Manual Compensation applied by
dragging mCherry population back to
the upper right quadrant where
mCherry is gated appropriately.

In order to only account for live cells during the apoptosis assay, all dead cells
need to be removed from the whole cell population in each iindividual
ndividual sample. This was
performed by incubating cells with 1X DAPI (4',6-diamidino-2-phenylindole
phenylindole) for 1
minute
ute prior to analysis. D
Dead cells have ruptured membranes and are permeable to
DAPI, which binds with high affinity to DNA whereas live cells exclude this dye. When
viewed on a flow cytometry plot, the DAPI
DAPI-stained population is clearly visible, allowing
the operator to adjust the live/dead gate appropriately (Figure 20).

FIGURE 20: Live/Dead gating using DAPI
FSA = Forward scattering which measures the size of each
individual cell as an event. BSC = Back scattering which
measure cell complexity. (Left) Fragmented cells and
cellular
llular debris is found during events measuring less than
238 on the FSC horizontal axis. (Right) Cells staining
positively for DAPI are gated appropriately and not
factored into the live cell population.

The presentation of phosphatidylserine to the outer leaflet of the cell membrane is
a characteristic hallmark of apoptosis. To determine the approximate number of cells
undergoing apoptosis during the assay, cells were incubated with Cy5 labeled annexin V,
which has a high binding affinity for phosphotidylserine. To validate our assay and
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induce a major shift in the Cy5-Annexin V positive cell population, hydrogen peroxide
(H2O2) was used to increase cellular stress and trigger apoptosis (Figure 21).
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EphA Receptor Knockdown in Stem Cells
Investigation of the role of EphA receptors in stem cell maintenance was
prompted by our observation that EphA4 is expressed in mESCs and throughout
differentiation (Figure 2). This lead us to ask whether EphA3, EphA4 or EphA7 had any
role in maintaining cells in the stem state. To address this, EphA3, EphA4, and EphA7
siRNAs were transfected into undifferentiated Oct4-GFP stem cells 24 hours prior to
analysis (Figure 22).

Sample
Sham
GFP
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0
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3.1
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FIGURE 22: GFP knockdown on day 0 stem cells

20
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0
Sham

GFP
EphA3
Type of siRNA

EphA4

EphA7

Undifferentiated mouse embryonic stem cells were lifted
and transfected in suspension with 500ng of siRNA and
plated onto gelatin-coated wells of a 24-well plate. Cells
were analyzed by FACS using DAPI staining for
live/dead gating. Error bars are representative of
experiment performed in triplicate.

The percent difference between the sham and the GFP siRNA transfected sample
is about 17% thus confirming that the transfections had occurred. There is not a
significant difference between the EphA siRNA transfected samples and the sham
transfected. To increase the probability of observing a shift in GFP expression, mCherry
was added to gate specifically for the siRNA transfected samples (Figure 23).

FACS Quantification

% of Cells Expressing GFP

70.0
60.0

55.6

52.0

53.0

52.2

50.0
40.0
FIGURE 23: mCherry co-transfection with EphA
siRNA in Oct4-GFP stem cells

30.0
20.0
10.0
0.0
Cherry

EphA3

EphA4

Type of siRNA

EphA7

Undifferentiated mouse embryonic stem cells were lifted
and transfected in suspension with 250ng of EphA
siRNA and 500ng of mCherry. Then plated onto gelatincoated wells of a 24-well plate. Cells were analyzed by
FACS using DAPI staining for live/dead gating. Error
bars are representative of experiment performed in
triplicate.

Oct4-GFP expression was maintained at about 80% throughout, irrespective of
which EphA was knocked down (Figure 22) and even with transfection gate provided by
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the mCherry co-transfection plasmid (Figure 23) there is not a dramatic difference
between EphA KD GFP expressions. It can be concluded that EphA signaling has no
obvious role in maintaining stem cell state.
Bioinformatics Assessment of Potential Cross-Binding
To ensure that transfected GFP siRNA was not knocking down our mCherry cotransfection control, we performed BLAST searches of the GFP siRNA products to
analyze for possible cross binding to mCherry (See Appendix B)(53) . In order to achieve
degradation of mRNA, 100% homology matching of 23 base pairs must be accomplished.
Less than 100% may possibly provide disruption in translation but not necessarily
targeted degradation. Cherry and GFP react at 100% with 23 base pairs and 100% with
18 base pairs. Keeping in mind that at 100% homology match for a 23 base pair fragment
out of a possible 750 base pair length GFP fragment is about a 3% chance of providing a
gene silencing effect. However, we may still observe an off-target effect from GFP to
mCherry.
Alternative Media and Differentiation Supplements
A cost effective option to the Invitrogen supplied supplement is GEM 21 supplied
by Gemini Biosciences. Differentiation was initiated at day 0 by plating cultured stem
cells on 0.1% gelatin-coated plastic surfaces at low density in N2B27 media. An initial
seeding density of 2.1x105 cells per plate was initiated on a total of 6x6cm plates.
However, we could not generate any viable neurons using this tissue culture
supplement. The neurons when resuspended in GEM 21 N2B27 will adhere to gelatincoated surfaces as normal but upon day 2 post-differentiation, they are struggling to
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survive.

In lieu of Neurobasal, Neuroplex, which is compatible with the GEM 21

supplements, was proven equivalent to the Neurobasal media during stem cell
differentiations (data not shown).
EphA Receptor Knockdown in Neuroblasts
To test whether siRNA knockdown
knockdowns were effective in neuroblasts,
neuroblast GFP, EphA3,
EphA4, and EphA7 siRNA transfections were performed at Day 5 post-differentiation
post
and analyzed by flow cytometry 24 – 72 hours later. The samples were run on both the
Accuri (data not shown) and the Sony (Figure 24); both instruments yielded comparable
results. We find that 72 hours post
post-transfection, apoptotic cells were around 8% of the
entire cell population, and the only significant difference was the EphA7 siRNA
transfected sample, which was 5.8% Cy5 positive. This result gave us insight that EphA7
knockdown resulted in a decrease of apoptotic cells in the sample population concluding
that EphA7 plays a role in promoting apoptosis.

Furthermore, EphA3 and EphA4

knockdown provided minimal changes in apoptosis levels indicating they play no roles in
regulating cell progenitor pool size.
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FIGURE 24: EphA knockdown in neuroblast

0.0

Sox1-GFP mouse embryonic stem cells were plated onto
gelatin coated 6cm dishes at low density. At day 5 they
were transfected in Optimem for 24 hours then the media
replaced with N2B27 media. Cells were lifted and
analyzed 72 hours post-differentiated.

We wanted to determine what time point gave us the best observation of
apoptosis. To do this, we examined assayed for apoptosis at 24, 48, and 72 hours posttransfection. In this time course a gradual reduction in GFP expression was observed,
which is to be expected of Oct4-GFP cells leaving the stem state and entering proneuronal fate (data not shown). The EphA7 siRNA transfected sample is a third less Cy5
positive than the mCherry transfected sample at 24 hours (Figure 25). However, at 48 and
72 hours post-transfection the EphA7 siRNA knockdown sample yields comparable
levels of Cy5 positive cells when compared to the mCherry-transfected control. This
suggests that 24 hours is optimal to view changes to apoptosis level due to EphA
knockdown. At 48 and 72 hours post-knockdown, it is likely that the knockdown by
siRNA is no longer effective (Figure 25). Whereas, at Day 5 EphA7 expression levels are
maximal (Figure 2) and knockdown effects may take up to 72 hours to observe a shift in
apoptotic activity (Figure 24).
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Timecourse Apoptosis
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FIGURE 25: Day 3 neuroblasts knockdown
time course

Control

25
20

Oct4-GFP mouse embryonic stem cells were
plated onto gelatin-coated surfaces at low
density in N2B27 differentiation media. At day
3 they were transfected in optimem for 24 hours
with EphA7 siRNA and a co-transfection
control (mCherry). After 24 hours the cells were
returned to N2B27 media. They were lifted and
analyzed 24, 48, and 72 hours post-transfection.
The samples were run on the SH800 and
analyzed for apoptosis using Annexin-Cy5
staining.

Control +
EphA7 siRNA

15
10
5
0
24

48

72

# Hours Post-Transfection

Following out extensive method development, we assayed a single time point in
triplicate using sham vs. EphA7 siRNA transfected samples. These were run without the
mCherry co-transfection plasmid to remove any subjectivity involved with manual
compensation. We found a 60% decrease in Cy5-AnnexinV stained cells after
transfection with EphA7 siRNA when compared to sham-transfected controls (Figure
26). Student t-test of the two samples lead to a P value =0.0144. We conclude that
apoptosis levels in EphA7 siRNA-treated cells are significantly different from sham
controls. This data strongly suggest that EphA7 is playing a role in promoting apoptosis.
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FIGURE 27: Apoptosis analysis on day 7 neuroblasts.

6.31

Sham

EphA7 siRNA

Day 6 neuroblast were lifted off laminin-coated
coated surfaces,
transfected in OPTIMEM and returned to laminin-coated
laminin
wells of a 24-well
well plate. 24 hours post siRNA transfection;
the cells were stained with Cy5-AnnexinV
AnnexinV and DAPI then
analyzed on the SH800 in triplicate.
licate. N = 3 experiments.
Error bars are standard error of the mean.
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CHAPTER 4. DISCUSSION

This thesis aimed to investigate the role of EphA receptor signaling in apoptosis
during in vitro neurogenesis. Our original hypothesis was that (1) Eph receptor and
ephrin expression is conserved during in vitro stem cell-to-forebrain differentiation and
(2) EphR/ephrin signaling was functioning to balance apoptosis during neural
development. The hypothesis was tested directly by developing an in vitro system using a
stem cell-to-forebrain model with two different stem cell lines, Sox1-GFP and Oct4-GFP,
to monitor the stem cell-to-neuron transition while characterizing changes in apoptosis
levels. The Sox1-GFP cell line is a knock-in reporter ES cell line in which there is a
random insertion of a Sox1 promoter driving GFP expression. In the neuroectoderm of
the mouse embryo, Sox1 is the earliest marker of neural development (58) . The Oct4
gene was discovered as a primary maintenance gene to maintain stem cell pluripotency
and gave rise to the Oct4-GFP mESC line in 2003 (59, 60) . Layer-specific cortical
neurogenesis is conserved during embryonic stem cell to neuron differentiations(61) .
Our qRT-PCR data support and extend these observations. In addition, we find that Eph
and ephrin expression during in vitro differentiation broadly mirrors previously published
in vivo data, further suggesting that we can recapitulate elements of cortical neurogenesis
in vitro (11) .
An additional goal was to investigate if EphA receptors had any role in
maintaining stem cell pluripotency. Currently there is no literature surrounding the idea
that Eph/ephrin signaling is involved in maintaining stem cell pluripotent state. We chose
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to investigate this because preliminary data shows EphA4 expression in mESCs and
throughout differentiation (Figure 2). We found that Oct4-GFP expression was
maintained at about 80% throughout, irrespective of which EphA was knocked down,
suggesting that EphA signaling has no obvious role in the maintenance of stem cell fate.
The inkling that EphR/ephrin signaling may be functioning in vitro to balance apoptosis
during neural development was prompted upon discovery of a recent publication that
displays an obvious reduction in apoptosis due to loss of EphA7 by mutation in an in vivo
study(55) . This work demonstrates the significance of region-specific apoptosis
involving ephrin signaling (55) . Data revealed in this thesis provides substantiating
evidence that EphA7 knockdown led to a reduction in apoptosis levels during in vitro
neural differentiation, indicating that EphA7 promotes apoptosis during in vitro neural
differentiation. This concurs with data from an in vivo study that implicate ephrinA5 and
EphA7 in balancing cortical apoptosis to control overall neuronal mass (43) . Additional
support demonstrates that over-expression of ephrinA5, driven from the EphA7 promoter,
can lead to increased apoptosis (62) .
We assayed apoptosis using flow cytometry. Cy5-labeled Annexin-V was used to
quantify the cells undergoing apoptosis by binding to cell-surface phosphotidylserine.
Also, DAPI staining was used to identify dead cells (which could potentially also display
phosphatidyl serine on the cell surface) because it binds very quickly to dead cells’ DNA
by penetrating the partially ruptured cell membranes. This proved to be useful for
live/dead gating of cell populations. In addition, incorporation of the mCherry cotransfection plasmid to detect successful transfection of our RNAi constructs was thought
to be a useful efficiency control. Unfortunately, the use of both mCherry and Cy5-
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AnnexinV on the FACS required the use of manual compensation due to major spectral
overlap, hence mCherry was removed from subsequent experiments. mCherry is driven
by the pCAGGS promoter, which is a very strong promoter, this lead to very high
expression levels of the mCherry plasmid causing the signal to overpower that of the
weaker Cy5 fluorophore.
Elaboration of a four-color fluorescent experiment enabled the ability to quantify
cells in different stages of apoptosis and death in different cell populations. Transfecting
siRNA for successful gene inhibition was proven as a practical method. Findings from
this project allowed for visualization of how exactly EphA7 is participating in cortical
maturation through apoptotic mechanisms.
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CHAPTER 5. CONCLUSIONS AND FUTURE WORK

Conclusions
Because ephrins play a role in neurogenesis and literature has shown that they can
control brain size in vivo, our ability to recapitulate these results during an in vitro study
has proven to be valuable discovery that can contribute to scientific advancement. The
primary objective of this thesis was to use a stem cell model of neural differentiation to
determine if EphA3, EphA4, or EphA7 had any role in apoptosis during in vitro
differentiation.
To investigate if EphA receptors had any role in maintaining stem cell
pluripotency, EphA knockdown in Day 0 cells did not cause them to differentiate. The
GFP expression in Oct4-GFP stem cells was maintained levels throughout the
transfection with siRNA from EphA3, EphA4, and EphA7. This concluded that cells
could still maintain their pluripotent state and resist differentiation during EphA receptor
knockdown generating a negative result.
Knocking down GFP expression in Oct4-GFP stem cells and Sox1-GFP
neuroblasts validated the siRNA transfection assays. We then assayed apoptosis during in
vitro neural development by using ezRNAi transfections to knockdown of EphA3,
EphA4, and EphA7 receptor expression. The knockdown of EphA3 and EphA4 had little
to no effect on the number of Cy5 positive cells indicating that they have no role in the
regulation of apoptosis during neuroblast differentiation. Finally, EphA7 knockdown lead
to a reduction in apoptosis at all stages of neural differentiation assayed (day 3 through
day 8). This finding confirms our original hypothesis to be correct.
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Demonstrating that EphA7 receptor signaling plays a role in neuroblast survival
during in vitro differentiation is a significant and novel body of research. Future findings
may prove to be useful in the discovery and outline of more connections in other
developmental processes as well as providing potential molecular targets for therapeutic
applications in oncology(63) .
Future Work
Aside from what has been delineated in the finding of this thesis, additional
experiments are worth mentioning in this chapter. One additional objective is to
determine the mechanism of apoptosis triggered by Eph/ephrin signaling in vitro.
Whether it is cross talk via death receptors or direct interaction with one or more of the
caspases is not known and would make for a compelling future project.
Working with neural spheres in culture followed by Cryostat-sectioning and
immunostaining for known apoptotic markers (e.g. cleaved caspase or TUNEL staining)
could provide the opportunity to gain further insight into the role of apoptosis in neuronal
precursor cells. This method allows for retention of neuronal morphology in relation to
surrounding cells and may represent a closer in vitro approximation to in vivo neural
development. For instance, by exploring neurospheres in culture we can examine the
neuronal layering associated with in vivo cortical development.
Alternatively, by plating cells onto cover slips, we can assay for apoptosis via
immunohistochemistry. We also plan to stimulate apoptosis using antibody-clustered
EphrinA5 and expect to see an increase in apoptosis. Lastly, continuing research includes
studying additional receptors, additional ligands, and/or additional timepoints.
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APPENDIX A

mh844 Primer designs for ezRNAi

12.17.13

Products on intended target

>NM_010140.3 Mus musculus Eph receptor A3 (Epha3), mRNA
product length = 527
Forward primer 1 GAGCGGAGCATGGTAACTTCT 21
Template

8 ..................... 28

Reverse primer 1
Template

TCGTGAACTGATGCTCTCGG 20

534 .................... 515

Products on intended target

>NM_007936.3 Mus musculus Eph receptor A4 (Epha4), mRNA
product length = 567
Forward primer 1
Template

2323 .................... 2342

Reverse primer 1
Template

AGCAACTTGGTCTGCAAGGT 20

AACCACGGCTTCTAGTGTCG 20

2889 .................... 2870

Products on intended target

>NM_010141.3 Mus musculus Eph receptor A7 (Epha7), transcript variant 1, mRNA
product length = 639
Forward primer 1
Template

1524 .................... 1543

Reverse primer 1
Template

AGGCTCTTCGCTGCTGTTAG 20

TGCACCAATCACACGCTCAA 20

2162 .................... 2143
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Primers (ordered 12.17.13)
EphA3F1

GAGCGGAGCATGGTAACTTCT

EphA3R1

TCGTGAACTGATGCTCTCGG

EphA4F1

AGCAACTTGGTCTGCAAGGT

EphA4R1

AACCACGGCTTCTAGTGTCG

EphA7F1

AGGCTCTTCGCTGCTGTTAG

EphA7R1

TGCACCAATCACACGCTCAA

Forward primer- 5' -TCACTATAGGGAGAG- original forward primer- gene-3'
Reverse primer-5' -TCACTATAGGGAGAC- original reverse primer-gene-3'

Redesigned primer set:

EphA3F1

TCACTATAGGGAGAGGAGCGGAGCATGGTAACTTCT

EphA3R1

TCACTATAGGGAGACTCGTGAACTGATGCTCTCGG

EphA4F1

TCACTATAGGGAGAGAGCAACTTGGTCTGCAAGGT

EphA4R1

TCACTATAGGGAGACAACCACGGCTTCTAGTGTCG

EphA7F1

TCACTATAGGGAGAGAGGCTCTTCGCTGCTGTTAG

EphA7R1

TCACTATAGGGAGACTGCACCAATCACACGCTCAA
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